Aspen Aerogels vs Hudson Technologies
ASPN and HDSN side by side, both in wholesale trade-durable goods. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ASPN and HDSN compare
Aspen Aerogels is the larger company, worth 2.4 times as much as Hudson Technologies ($407M against $173M).
Hudson Technologies grew revenue faster over the last twelve months (14.3% versus −49.1% for Aspen Aerogels).
Hudson Technologies keeps more of each dollar of sales as profit, with a net margin of 3.5% compared with −62.4% at Aspen Aerogels.
Hudson Technologies scores higher on the StockData Score (11 against 4 for Aspen Aerogels), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ASPN | HDSN |
|---|---|---|
| Size and price | ||
| Market cap | $407M | $173M |
| Share price | $4.90 | $4.11 |
| Change, 1 year | 59.1% | −39.5% |
| Change, 5 years | −91.5% | 4.3% |
| Beta (5Y) | 2.62 | 0.84 |
| Employees | 854 | 281 |
| StockData Score | ||
| Total score | 4 | 11 (better) |
| Valuation score | 0 | 4 (better) |
| Growth score | 1 | 1 |
| Performance score | 0 | 0 |
| Health score | 3 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 19.6× |
| P/S | 2.0× | 0.7× (better) |
| P/B | 2.1× | 0.7× (better) |
| EV/EBITDA | – | 10.1× |
| P/FCF | 11.8× | – |
| FCF yield | 8.5% (better) | −20.0% |
| Fair value | $4.59 | $5.63 |
| Margin of safety | −6.7% | 27.0% (better) |
| Growth | ||
| Revenue growth (TTM) | −49.1% | 14.3% (better) |
| Revenue growth, 5Y average | 22.0% (better) | 10.8% |
| Net income growth (TTM) | – | −50.4% |
| EPS growth (TTM) | – | −47.5% |
| Profitability | ||
| Gross margin | 2.7% | 23.3% (better) |
| Operating margin | −61.0% | 4.5% (better) |
| Net margin | −62.4% | 3.5% (better) |
| FCF margin | 17.0% (better) | −13.4% |
| Return on equity | −50.4% | 3.6% (better) |
| Return on invested capital | −84.3% | 3.7% (better) |
| Financial health | ||
| Debt / equity | 0.12 (better) | 0.00 |
| Current ratio | 2.52 | 3.23 (better) |
| Altman Z-score | −2.75 | 3.48 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Buyback yield | – | 10.4% |
| Shareholder yield | 0.00% | 10.4% (better) |
| Ownership | ||
| Held by institutions | 88.5% | 75.1% |
| Held by insiders | 16.8% | 14.1% |
| Insider net buying, 12 months | −$58.1M | $903K (better) |
| Short interest, % of float | 9.3% | 7.1% |
Go deeper
- ASPN stock overview
- ASPN income statement
- ASPN valuation and score
- HDSN stock overview
- HDSN income statement
- HDSN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.